←Back to Expert Scholars
Translational Medicine / 转化医学Precision Oncology, NCI MATCH
Keith Flaherty
MD
🏢Massachusetts General Hospital Cancer Center🌐USA
Director Clinical Research
140
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Keith Flaherty co led the NCI-MATCH precision oncology trial and has shaped targeted therapy development in melanoma and across tumors. His work established BRAF and MEK inhibitor combinations in melanoma and advanced tissue agnostic trial design. He directs clinical research at Mass General Cancer Center.
Share:
🧪Research Fields 研究领域
precision oncology
NCI MATCH
BRAF
melanoma
molecular tumor board
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Keith Flaherty 的研究动态
Follow Keith Flaherty's research updates
留下邮箱，当我们发布与 Keith Flaherty（Massachusetts General Hospital Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment